Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Seiichi Takagi"'
Autor:
Kento Nakatani, Kenji Ishido, Ken Nishimura, Seiichi Takagi, Satoshi Tanabe, Tohru Sasaki, Norisuke Nakayama, Takako Ae, Mizutomo Azuma, Akira Naruke, Chikatoshi Katada, Katsuhiko Higuchi, Wasaburo Koizumi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:407-413
We conducted a phase II study to evaluate the efficacy and safety of a triplet regimen of docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer.Docetaxel (40 mg/m(2)) and cisplatin (70 or 60 mg/m(2)) were given on da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688ad55c9a99023d9c9369f695cc8765
https://doi.org/10.1007/s00280-011-1701-1
https://doi.org/10.1007/s00280-011-1701-1
Autor:
Seiichi Takagi, Norisuke Nakayama, Satoru Iwasa, Tetsuya Hamaguchi, Yasuhiro Shimada, Yushi Nagai, Akihito Tsuji, Takako E. Nakajima, Ken Kato, Junichi Matsubara, Yasuhide Yamada, Kazuma Kobayashi, Akira Yoshioka
Publikováno v:
Oncology. 81:291-297
Objective: We evaluated the efficacy and safety of bolus 5-fluorouracil (5-FU) and leucovorin combined with weekly paclitaxel (FLTAX) in advanced gastric cancer (GC) patients. Methods: Patients with untreated stage IV GC received paclitaxel 80 mg/m2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811fb29a36e4bb48f27838031dd0dfa0
https://doi.org/10.1159/000334462
https://doi.org/10.1159/000334462
Publikováno v:
Digestive Endoscopy. 21:176-179
Background: We have been attempting to improve the safety, reliability and simplicity of endoscopic submucosal dissection for the treatment of early esophageal cancer and to shorten the time needed for this operation. Methods: The present study invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62613515814e0f798af41923253c740
https://doi.org/10.1111/j.1443-1661.2009.00881.x
https://doi.org/10.1111/j.1443-1661.2009.00881.x
Autor:
Seiichi Takagi, Tohru Sasaki, Norisuke Nakayama, Wasaburo Koizumi, Katsuhiko Higuchi, Katsunori Saigenji, Kento Nakatani, Ken Nishimura, Chikatoshi Katada, Satoshi Tanabe
Publikováno v:
Oncology. 75:1-7
Objective: This dose-escalation study of a combination of docetaxel, cisplatin and S-1 investigated the dose-limiting toxicity (DLT), maximum-tolerated dose (MTD), recommended dose (RD) and antitumor activity in advanced gastric cancer. Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35495ca9cc9f3c46a69ebf4e1d3e5b2
https://doi.org/10.1159/000151613
https://doi.org/10.1159/000151613
Safety and utility of new ESD technique using transparent hood with mucosa gripping channel attached
Autor:
Takako Yoshii, Osamu Motohashi, Seiichi Takagi, Naoki Yanagida, Atsushi Kiyohashi, Youichi Kameda, Norisuke Nakayama, Kyoko Yonemitsu
Publikováno v:
Progress of Digestive Endoscopy. 68:24-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1447443d75056bf7d9fa997e4e2e6e9c
https://doi.org/10.11641/pde.68.2_24
https://doi.org/10.11641/pde.68.2_24
Autor:
Akihito, Momoi, Shigeki, Motomura, Chizuko, Hashimoto, Hirotaka, Takasaki, Sachiya, Takemura, Seiichi, Takagi, Makoto, Akaike
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(1)
Bevacizumab (BV) is widely used for patients with metastatic colorectal cancer. We investigated the efficacy and safety of chemotherapy combined with BV for metastatic colorectal cancer. From July 2007 to October 2008, 59 patients were treated by che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::948c85acee25abcbd37b33ee309b5be2
https://pubmed.ncbi.nlm.nih.gov/21368462
https://pubmed.ncbi.nlm.nih.gov/21368462
Autor:
Hisahiko Motohashi, Youichi Kameda, Osamu Motohashi, Hideya Sano, Atsushi Kiyohashi, Seiichi Takagi
Publikováno v:
Progress of Digestive Endoscopy(1972). 43:166-169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd76448c75d7a6ceee53aaafa7cd142b
https://doi.org/10.11641/pdensks.43.0_166
https://doi.org/10.11641/pdensks.43.0_166
Autor:
Seiichi Takagi, Osamu Motohashi, Atsushi Kiyohashi, Hisahiko Motohashi, Yoshihiko Ito, Hideya Sano, Masahiro Katagiri, Tsuruyo Takano, Shinichi Okawa, Setsuo Tamai, Kazuo Tarao
Publikováno v:
Progress of Digestive Endoscopy(1972). 42:185-188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f6c97f8cbe41b0570224d8a90735d97
https://doi.org/10.11641/pdensks.42.0_185
https://doi.org/10.11641/pdensks.42.0_185
Autor:
Manabu, Shiozawa, Ken, Nishimura, Tetsuo, Nonaka, Takako, Yoshii, Norisuke, Nakayama, Osamu, Motohashi, Seiichi, Takagi, Yuko, Nakayama, Makoto, Akaike
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(13)
We report three cases of anal canal squamous cell carcinoma treated with radiotherapy combined with S-1 and mitomycin C(MMC). During radiotherapy, MMC was administered as intravenous bolus injection at a dose of 10mg/m2 on day 1 and 29. S-1 was admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15ec0c795477a0dff40b0c88a328bc00
https://pubmed.ncbi.nlm.nih.gov/21160276
https://pubmed.ncbi.nlm.nih.gov/21160276
Autor:
Toshikazu Akiya, Takashi Nagaie, Takashi Nishizaki, Osamu Kobayashi, Yoshitaka Yamamura, Seiichi Takagi, Hiroyuki Orita, Wasaburo Koizumi, Akinori Takagane, Wataru Takiyama, Kosei Miyashita, Yasushi Toh, H. Narahara, Masahiro Takeuchi, Masakazu Takagi, Kimihiko Yanaoka, Takuo Hara
Publikováno v:
The Lancet. Oncology. 9(3)
Phase I/II clinical trials of S-1 plus cisplatin for advanced gastric cancer have yielded good responses and the treatment was well tolerated. In this S-1 Plus cisplatin versus S-1 In RCT In the Treatment for Stomach cancer (SPIRITS) trial, we aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8870124b6aaecc98693626464753a0f6
https://pubmed.ncbi.nlm.nih.gov/18628737
https://pubmed.ncbi.nlm.nih.gov/18628737